David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Ionis Pharmaceuticals $632.5 million convertible senior notes offering
We advised the purchasers on the Rule 144A convertible notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
Beam Therapeutics $300 million at-the-market offering
We advised the sales agent in connection with the equity offering
Bridgepoint acquisition of Sun World International
We are advising Bridgepoint on the acquisition
LAVA Therapeutics $100.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing